Rosenberg Matthew Hamilton Abbott Laboratories Transaction History

Rosenberg Matthew Hamilton

$426 Million
Q2 2025

A detailed history of Rosenberg Matthew Hamilton transactions in Abbott Laboratories stock. As of the latest transaction made, Rosenberg Matthew Hamilton holds 2,010 shares of ABT stock, worth $270,525. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,010

Previous 1,762 14.07%

Holding current value

$270,525

Previous $233,000 17.17%

% of portfolio

0.06%

Previous 0.06%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 28, 2025	BUY	$123.95 - $138.08 $30,739 - $34,243	248 Added 14.07%	2,010 $273,000
Q1 2025 Apr 28, 2025	BUY	$111.1 - $140.22 $9,776 - $12,339	88 Added 5.26%	1,762 $233,000
Q4 2024 Jan 13, 2025	BUY	$111.93 - $119.39 $2,350 - $2,507	21 Added 1.27%	1,674 $189,000
Q3 2024 Oct 28, 2024	BUY	$100.07 - $118.13 $11,508 - $13,584	115 Added 7.48%	1,653 $188,000
Q2 2024 Jul 26, 2024	SELL	$100.73 - $112.44 $11,886 - $13,267	-118 Reduced 7.13%	1,538 $159,000
Q1 2024 Apr 19, 2024	SELL	$109.52 - $120.96 $3,176 - $3,507	-29 Reduced 1.72%	1,656 $188,000
Q4 2023 Jan 12, 2024	SELL	$90.19 - $110.4 $23,629 - $28,924	-262 Reduced 13.46%	1,685 $185,000
Q3 2023 Oct 11, 2023	SELL	$95.53 - $114.62 $2,770 - $3,323	-29 Reduced 1.47%	1,947 $188,000
Q2 2023 Jul 26, 2023	SELL	$100.78 - $112.29 $30,939 - $34,473	-307 Reduced 13.45%	1,976 $215,000
Q1 2023 Apr 17, 2023	BUY	$96.86 - $114.01 $3,099 - $3,648	32 Added 1.42%	2,283 $231,000
Q4 2022 Jan 18, 2023	SELL	$95.06 - $111.52 $7,129 - $8,364	-75 Reduced 3.22%	2,251 $0
Q3 2022 Oct 21, 2022	SELL	$96.76 - $112.03 $3,870 - $4,481	-40 Reduced 1.69%	2,326 $225,000
Q2 2022 Jul 15, 2022	BUY	$102.07 - $123.37 $10,921 - $13,200	107 Added 4.74%	2,366 $261,000
Q1 2022 Apr 14, 2022	BUY	$114.02 - $139.04 $29,417 - $35,872	258 Added 12.89%	2,259 $267,000
Q4 2021 Jan 20, 2022	SELL	$115.53 - $141.46 $5,660 - $6,931	-49 Reduced 2.39%	2,001 $282,000
Q3 2021 Oct 12, 2021	BUY	$116.66 - $129.06 $47,713 - $52,785	409 Added 24.92%	2,050 $242,000
Q1 2021 Apr 30, 2021	SELL	$108.84 - $128.23 $36,461 - $42,957	-335 Reduced 16.95%	1,641 $197,000
Q2 2020 Aug 04, 2020	BUY	$76.57 - $98.0 $13,016 - $16,660	170 Added 9.41%	1,976 $181,000
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $113,452 - $165,899	1,806 New	1,806 $143,000

Others Institutions Holding ABT

# of Institutions

3,600

Shares Held

1.4B

Call Options Held

9.23M

Put Options Held

8.1M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $236B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rosenberg Matthew Hamilton, based on Form 13F filings with the SEC.

News

Stay updated on Rosenberg Matthew Hamilton with notifications on news.

Account

Rosenberg Matthew Hamilton Abbott Laboratories Transaction History